ARQT vs SHW · rev $235.3M vs P/E 29, rev $12.46B
Arcutis Biotherapeutics Inc (ARQT) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported ARQT revenue for 2026-06-30 was $235.3M. Net income was $3.7M. ARQT currently screens at market cap $1.64B.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
ARQT currently screens at market cap $1.64B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the ARQT and SHW stock pages for the full models.
Not investment advice.